Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.

Liu Y, Yan R, Song A, Niu X, Cao C, Wei J, Dong X, Gao D.

Am J Hypertens. 2014 Feb;27(2):268-78. doi: 10.1093/ajh/hpt210. Epub 2013 Dec 4.

PMID:
24304656
[PubMed - indexed for MEDLINE]
2.

Aliskiren vs. other antihypertensive drugs in the treatment of hypertension: a meta-analysis.

Chen Y, Meng L, Shao H, Yu F.

Hypertens Res. 2013 Mar;36(3):252-61. doi: 10.1038/hr.2012.185. Epub 2012 Nov 15.

PMID:
23154589
[PubMed - indexed for MEDLINE]
3.

Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.

Stanton AV, Gradman AH, Schmieder RE, Nussberger J, Sarangapani R, Prescott MF.

Hypertension. 2010 Jan;55(1):54-60. doi: 10.1161/HYPERTENSIONAHA.109.135772. Epub 2009 Nov 16.

PMID:
19917876
[PubMed - indexed for MEDLINE]
Free Article
4.

First renin inhibitor, aliskiren, for the treatment of hypertension.

Triller DM, Evang SD, Tadrous M, Yoo BK.

Pharm World Sci. 2008 Dec;30(6):741-9. doi: 10.1007/s11096-008-9252-1. Epub 2008 Sep 18. Review.

PMID:
18802783
[PubMed - indexed for MEDLINE]
5.

Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.

Baguet JP, Legallicier B, Auquier P, Robitail S.

Clin Drug Investig. 2007;27(11):735-53.

PMID:
17914893
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk